Early acute kidney injury is a risk factor that predicts mortality in patients treated with colistin

Nephron - Clinical Practice

Volumn 117, Issue 3, 2011, Pages

  Ko, Hee Ja ^a   Jeon, Min Hyok ^a   Choo, Eun Ju ^a   Lee, Eun Jung ^a   Kim, Tae Hyong ^a   Jun, Jae Bum ^b   Gil, Hyo Wook ^a  

^a Soonchunhyang University   (South Korea)

^b Ulsan University College of Medicine   (South Korea)

Author keywords

Acute renal failure; Colistin; Mortality

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; AMINOGLYCOSIDE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; COLISTIMETHATE; CREATININE; VANCOMYCIN;

ABDOMINAL ABSCESS; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; APACHE; ARTICLE; ARTIFICIAL VENTILATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTEREMIA; BILIRUBIN BLOOD LEVEL; CATHETER INFECTION; CENTRAL VENOUS CATHETER RELATED INFECTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG SAFETY; FEMALE; HEMATOCRIT; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; KIDNEY INJURY; LEUKOCYTE COUNT; LIVER CIRRHOSIS; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURGICAL INFECTION; TREATMENT DURATION; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; URINARY TRACT INFECTION;

ACUTE KIDNEY INJURY; AGED; ANTI-BACTERIAL AGENTS; COLISTIN; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77956575315     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320746     Document Type: Article

References (15)

1. Falagas ME, Rafailidis PI: Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives. Expert Opin Investig Drugs 2008;17:973-981.
2. Falagas ME, Kasiakou SK: Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections. Clin Infect Dis 2005;40:1333-1341. (Pubitemid 40570245)
3. Falagas ME, Fragoulis KN, Kasiakou SK, Sermaidis GJ, Michalopoulos A: Nephrotoxicity of intravenous colistin: a prospective evaluation. Int J Antimicrob Agents 2005;26:504-507. (Pubitemid 41635502)
4. Garnacho-Montero J, Ortiz-Leyba C, Jiménez-Jiménez FJ, Barrero-Almodóvar AE, García-Garmendia JL, Bernabeu-Wittell M, Gallego-Lara SL, Madrazo-Osuna J: Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis 2003;36:1111-1118. (Pubitemid 36549630)
5. Hartzell JD, Neff R, Ake J, Howard R, Olson S, Paolino K, Vishnepolsky M, Weintrob A, Wortmann G: Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center. Clin Infect Dis 2009;48:1724-1728.
6. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative workgroup: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8: R204-R212.
7. Koch-Weser J, Sidel VW, Federman EB, Kanarek P, Finer DC, Eaton AE: Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann Intern Med 1970;72:857-868.
8. Berg JR, Spilker CM, Lewis SA: Modulation polymyxin B effects on mammalian urinary bladder. Am J Physiol 1998;275: F204-F215.
9. Kwon JA, Lee JE, Huh W, Peck KR, Kim YG, Kim DJ, Oh HY: Predictors of acute kidney injury associated with intravenous colistin treatment. Int J Antimicrob Agents 2010;35:473-477.
10. Cheng CY, Sheng WH, Wang JT, Chen YC, Chang SC: Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections. Int J Antimicrob Agents 2010;35:297-300.
11. Falagas ME, Rafailidis PI, Ioannidou E, Alexiou VG, Matthaiou DK, Karageorgopoulos DE, Kapaskelis A, Nikita D, Michalopoulos A: Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients. Int J Antimicrob Agents 2010;35:194-199.
12. Ricci Z, Cruz D, Ronco C: The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney Int 2008;73:538-546. (Pubitemid 351264114)
13. Paul M, Bishara J, Levcovich A, Chowers M, Goldberg E, Singer P, Lev S, Leon P, Raskin M, Yahav D, Leibovici L: Effectiveness and safety of colistin: prospective comparative cohort study. J Antimicrob Chemother 2010;65:1019-1027.
14. Ronco C: NGAL: diagnosing AKI as soon as possible. Critical Care 2007;11:173.
15. Soni SS, Ronco C, Katz N, Cruz DN: Early diagnosis of acute kidney injury: the promise of novel biomarkers. Blood Purif 2009;28:165-174.